MergerJul 20, 2026, 08:21 AM
Aptorum Group Completes DiamiR Merger, Rebrands to Niki BioSolutions
AI Summary
Aptorum Group Ltd completed its merger with DiamiR Biosciences Corp. on July 20, 2026, following shareholder approval. Concurrently, Aptorum redomiciled to Delaware, changed its name to Niki BioSolutions, Inc., and will trade on Nasdaq under the new ticker "NIKI" with a new CUSIP. The company also effected a 1-for-10 reverse stock split to maintain Nasdaq listing compliance and adopted a new 2026 Incentive Plan.
Key Highlights
- Merger with DiamiR Biosciences Corp. completed on July 20, 2026.
- Aptorum Group redomiciled to Delaware and changed its name to Niki BioSolutions, Inc.
- New Nasdaq trading symbol "NIKI" and CUSIP number 653942 102.
- Effected a 1-for-10 reverse stock split to maintain Nasdaq listing compliance.
- Aptorum shareholders received 814,375 Niki Common Stock and 179,693 Series A Preferred Stock.
- DiamiR stockholders received 1,979,216 shares of Niki Common Stock.
- Adopted the 2026 Equity Incentive Plan for employees, officers, directors, and consultants.
Price Impact
More from APM